Compounds > 1-cyano-2-hydroxy-3,4-epithiobutane
Page last updated: 2024-12-08
1-cyano-2-hydroxy-3,4-epithiobutane
Description
The chemical name 1-cyano-2-hydroxy-3,4-epithiobutane is not a recognized or commonly used chemical name. It is likely a combination of functional groups that could potentially lead to a variety of different chemical structures.
Let's break down the name to understand why it might be confusing:
* **1-cyano:** Indicates a cyano group (-CN) attached to the first carbon atom.
* **2-hydroxy:** Indicates a hydroxyl group (-OH) attached to the second carbon atom.
* **3,4-epithio:** Indicates a sulfur bridge (S) connecting the third and fourth carbon atoms.
* **butane:** A four-carbon chain.
The problem is that the combination of a sulfur bridge and a hydroxyl group on adjacent carbons is highly unusual. It's likely this chemical wouldn't be stable or readily synthesized.
**Possible explanations for the name:**
* **Typographical error:** It could be a mistake in the spelling or arrangement of the functional groups.
* **Simplified name:** It might be a simplified name for a more complex molecule with additional functionalities.
* **Hypothetical molecule:** It could be a name given to a hypothetical molecule for research purposes, but without further context, it's impossible to know what the structure might be.
**Importance for research:**
Without knowing the exact structure of the molecule, it's impossible to comment on its importance for research. However, molecules with cyano, hydroxyl, and sulfur groups are known to have a wide range of applications in various fields, including:
* **Organic synthesis:** These functional groups can be used as building blocks for synthesizing more complex molecules.
* **Pharmaceuticals:** Some molecules containing these functional groups exhibit biological activity and are used as pharmaceuticals.
* **Materials science:** These groups can influence the properties of materials, such as their conductivity or optical properties.
**To understand the importance of this molecule for research, more information is needed, such as:**
* **The exact chemical structure:** This is crucial for determining the molecule's properties and potential applications.
* **The research area:** Knowing the context of the research can provide insights into the molecule's importance.
* **The experimental results:** Any available data about the molecule's synthesis, characterization, or biological activity would be invaluable.
If you have any additional information about this molecule, please provide it so I can give you a more accurate and relevant answer.
1-cyano-2-hydroxy-3,4-epithiobutane: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 153007 |
SCHEMBL ID | 17225101 |
MeSH ID | M0050205 |
Synonyms (12)
Synonym |
3-hydroxy-3-(thiiran-2-yl)propanenitrile |
thiiranepropanenitrile, beta-hydroxy- |
30381-35-2 |
1-cyano-2-hydroxy-3,4-epithiobutane |
1-cyano-2-hydroxy-3,4-epithiobutan |
pentononitrile, 2,4,5-trideoxy-4,5-epithio- |
valeronitrile, 4,5-epithio-3-hydroxy- |
episulfide isomef a |
YHHMEZJFUCZIOV-UHFFFAOYSA-N |
thiiranepropanenitrile, .beta.-hydroxy- |
episulfide isomer 2 |
SCHEMBL17225101 |
Research Excerpts
Toxicity
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 4 (80.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.53
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.53 (24.57) | Research Supply Index | 1.79 (2.92) | Research Growth Index | 4.32 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |